Tru Independence Asset Management 2’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-15,123
Closed -$1.9M 137
2021
Q3
$1.9M Buy
15,123
+1,896
+14% +$245K 1.34% 16
2021
Q2
$1.64M Buy
13,227
+2,856
+28% +$359K 1.12% 22
2021
Q1
$1.23M Buy
10,371
+2,104
+25% +$247K 0.97% 25
2020
Q4
$968K Buy
+8,267
New +$910K 0.82% 31

Other funds holding MDT

Tru Independence Asset Management 2's MDT Position: Q4 2021 in Review

Tru Independence Asset Management 2 sold out of Medtronic (MDT) in Q4 2021, closing a stake of 15,123 shares — an estimated $1.9M sold.

Tru Independence Asset Management 2 first reported a position in MDT in Q4 2020 and held it in 4 quarters. The position peaked at $1.9M in Q3 2021. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.

  • Tru Independence Asset Management 2 reported no remaining Medtronic position as of Q4 2021 after selling out during the quarter.
  • Tru Independence Asset Management 2 sold 15,123 Medtronic shares in Q4 2021, an estimated $1.9M.
  • Tru Independence Asset Management 2 first reported a position in Medtronic in Q4 2020 and held it in 4 quarters.
  • Tru Independence Asset Management 2's Medtronic position peaked at $1.9M in Q3 2021.
  • 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.

Based on Tru Independence Asset Management 2's 13F filing for Q4 2021, filed 20 Jan 2022.